Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Two-stage sample size re-estimation based on a nuisance parameter: a review.

Michael A Proschan1

  • 1National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA. ProschaM@mail.nih.gov

Journal of Biopharmaceutical Statistics
|July 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Single Dose Study of Pembrolizumab in People With HIV Infection Who are Immunologic Nonresponders.

Open forum infectious diseases·2026
Same author

Response-adaptive randomization with imperfect intermediate endpoints.

Clinical trials (London, England)·2026
Same author

Event-driven planning of two-armed trials with a binary endpoint.

Clinical trials (London, England)·2026
Same author

Futility Monitoring in Clinical Trials.

Statistics in medicine·2025
Same author

Does Remdesivir Lower COVID-19 Mortality? A Subgroup Analysis of Hospitalized Adults Receiving Supplemental Oxygen.

Statistics in medicine·2024
Same author

Comparison of Bayesian and frequentist monitoring boundaries motivated by the Multiplatform Randomized Clinical Trial.

Clinical trials (London, England)·2024
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Calculating sample sizes for clinical trials is challenging due to parameter dependencies. This review examines two-stage methods using an initial pilot study to estimate parameters and adjust the final sample size for continuous or dichotomous outcomes.

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Statistical Inference

Background:

  • Accurate sample size calculation is crucial for clinical trial validity but often complicated by nuisance parameters and treatment effect uncertainty.
  • Traditional methods face challenges in precisely estimating these parameters beforehand.
  • Two-stage designs have emerged as a promising approach to address these complexities.

Purpose of the Study:

  • To review and synthesize existing two-stage sample size calculation methods for clinical trials.
  • To provide an overview of techniques applicable to both continuous and dichotomous outcome data.
  • To highlight the utility of internal pilot studies in refining sample size estimations.

Main Methods:

  • Literature review of two-stage clinical trial designs.

Related Experiment Videos

  • Focus on methods estimating nuisance parameters in the first stage.
  • Discussion of adaptations for continuous and dichotomous endpoints.

    • Main Results:

    • Two-stage methods allow for adaptive sample size adjustments based on pilot data.
    • Estimation of nuisance parameters is feasible and improves precision.
    • The review covers a range of established and novel two-stage approaches.

    Conclusions:

    • Two-stage methods offer a robust framework for sample size determination in clinical trials.
    • Utilizing an internal pilot study enhances the efficiency and accuracy of sample size planning.
    • These methods are adaptable to various clinical trial outcome types, improving statistical power and resource allocation.